查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1967701

寵物肥胖管理市場－全球產業規模、佔有率、趨勢、機會、預測：依動物類型、產品、通路、地區和競爭格局分類，2021-2031年

Pet Obesity Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Product, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球寵物肥胖管理市場預計將從 2025 年的 116.1 億美元成長到 2031 年的 171.6 億美元，複合年成長率為 6.73%。

此領域涵蓋旨在減輕伴侶動物體重的治療性營養補充劑、藥物介入和物理復健服務。推動該領域發展的關鍵因素包括寵物日益人性化、人們對肥胖相關併發症（如糖尿病和骨關節炎）的認知不斷提高，以及透過專業體重管理來改善久坐生活方式以延長寵物壽命的必要性。

市場概覽
預測期 2027-2031
市場規模：2025年 116.1億美元
市場規模：2031年 171.6億美元
複合年成長率：2026-2031年 6.73%
成長最快的細分市場 補充
最大的市場 北美洲

儘管存在這些積極因素，但寵物實際健康狀況與飼主認知之間的巨大差距阻礙了市場擴張。許多飼主未能準確識別寵物肥胖，導致治療延誤和對飲食限制的依從性不足。根據寵物肥胖預防協會 (APOP) 2024 年的數據，只有 35% 的狗主飼主33% 的貓飼主認為他們的寵物超重或肥胖，這凸顯了臨床實際情況與飼主認知之間的差距。這種認知差距限制了專業管理解決方案的消費群。

市場促進因素

全球寵物肥胖症的日益普遍是推動市場擴張和專業體重管理干預措施需求成長的主要動力。隨著過量攝取卡路里和缺乏運動成為普遍現象，與體重相關的疾病（例如代謝紊亂和骨關節炎）的激增迫使獸醫專業人員實施嚴格的管理通訊協定。根據英國寵物食品協會發布的《2024年肥胖症報告》，獸醫專業人員估計，英國目前有50%的犬和43%的貓超重或肥胖，這使得低熱量處方糧和復健服務的需求急劇上升。

同時，可支配收入的成長和寵物醫療保健支出的增加，在將醫療保健需求轉化為市場收入方面發揮著至關重要的作用。隨著寵物越來越被擬人化，飼主也越來越願意投資於高品質的獸醫護理和處方糧，以延長寵物的壽命。根據美國寵物用品協會 (APPA) 發布的《2024-2025 年全美寵物飼主調查》，2023 年美國寵物產業的總支出達到 1,470 億美元，這表明醫療費用支出潛力巨大。這種經濟基礎為治療方案的推廣提供了支持。寵物肥胖預防協會 (APOP) 在 2024 年 5 月發布的報告顯示，16% 的狗主飼主25% 的貓飼主使用治療性減重糧。

市場挑戰

全球寵物肥胖管理市場面臨的一個根本限制因素是寵物實際身體狀況與其飼主認知之間存在顯著差距。這種差異嚴重阻礙了市場滲透，因為不了解寵物體重問題的飼主不太可能尋求藥物干預或購買治療性營養補充劑。由於無法識別超重問題，導致無法進行必要的獸醫諮詢以製定管理方案，使得大量臨床上可治療的動物無法被製造商接觸到，儘管肥胖症的患病率很高，從而抑制了市場需求。

產業數據也印證了這項障礙的嚴重性。英國寵物食品公司2024年的報告顯示，獸醫專業人士將50%的犬隻和43%的貓咪歸類為超重或肥胖，而77%的飼主卻認為自己的寵物體重健康。這種鮮明的對比表明，絕大多數潛在消費者並不了解寵物的健康需求，市場也未能充分利用肥胖病例的實際規模。因此，阻礙收入成長的並非缺乏有效的治療方法，而是終端使用者無法辨識問題的根源。

市場趨勢

GLP-1受體促效劑的出現標誌著寵物減肥市場的轉捩點，使其從傳統的飲食限制轉變為類似於人類肥胖症治療的藥物干預。這些長效注射藥物利用生物機制來調節食慾和改善代謝功能，為嚴格的飲食管理提供了替代方案。根據《寵物食品產業》雜誌2025年4月的一篇報導，如果處方減重藥的安全性和有效性得到證實，大約三分之一的飼主願意為寵物使用此類藥物。這表明，隨著越來越多的飼主將體重管理納入醫療範疇以降低健康風險，此類藥物很可能迅速普及。

同時，穿戴式寵物活動追蹤器的引入正在改變寵物體重管理策略。其優點在於能夠提供客觀的能量消耗數據，進而幫助寵物克服久坐的習慣。與主觀觀察不同，這些設備利用加速計技術監測活動量和卡路里消耗，使獸醫能夠根據即時指標制定精準的運動計畫。這項技術有助於建立回饋機制，增強飼主的參與度和對康復通訊協定的依從性。 Tractive 於 2025 年 1 月發布的一份報告也印證了這一趨勢，該報告指出，使用其追蹤解決方案的活躍用戶數量已超過 130 萬。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球寵物肥胖管理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 動物種類（狗、貓、其他）
    • 依產品（治療性食品、補充品）
    • 分銷通路（寵物專賣店、電子商務、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美寵物肥胖管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲寵物肥胖管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區寵物肥胖管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲寵物肥胖管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲寵物肥胖管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球寵物肥胖管理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Mars Incorporated
  • Hill's Pet Nutrition, Inc.
  • Nestle SA
  • Farmina Pet Foods Holding BV
  • Drools Pet Food Pvt. Ltd.
  • NOW Health Group, Inc.
  • Virbac SA
  • VioVet Ltd
  • Rolf C. Hagen Inc.
  • Vivaldis Health & Foods Pvt. Ltd.
  • Neogen Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27321

The Global Pet Obesity Management Market is projected to expand from USD 11.61 Billion in 2025 to USD 17.16 Billion by 2031, registering a CAGR of 6.73%. This sector encompasses therapeutic nutritional formulations, pharmaceutical interventions, and physical rehabilitation services aimed at reducing excess body weight in companion animals. Growth is largely propelled by the increasing humanization of pets, a growing awareness of obesity-linked comorbidities like diabetes and osteoarthritis, and the need to address sedentary lifestyles through professional weight management to enhance pet longevity.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.61 Billion
Market Size 2031USD 17.16 Billion
CAGR 2026-20316.73%
Fastest Growing SegmentSupplements
Largest MarketNorth America

Despite these positive indicators, market expansion is hindered by a significant disconnect between actual pet health and owner perception. Many pet parents fail to identify overweight conditions accurately, resulting in delayed treatment and poor adherence to dietary restrictions. Data from the Association for Pet Obesity Prevention in 2024 reveals that only 35% of dog owners and 33% of cat owners classified their pets as overweight or obese, highlighting a gap between clinical reality and owner recognition that limits the consumer base for professional management solutions.

Market Driver

The increasing global prevalence of pet obesity acts as the primary catalyst for market expansion, necessitating professional weight management interventions. As caloric overconsumption and sedentary behaviors become normalized, the surge in weight-related pathologies, such as metabolic dysfunction and osteoarthritis, compels veterinary professionals to implement rigorous management protocols. According to the 'Obesity Report 2024' by UK Pet Food, veterinary professionals estimate that 50% of dogs and 43% of cats in the United Kingdom are currently overweight or obese, creating a non-discretionary demand for specialized low-calorie formulations and rehabilitation services.

Concurrently, rising disposable income and dedicated pet healthcare expenditure are crucial in translating medical needs into market revenue. As pet humanization intensifies, owners show a greater willingness to invest in premium veterinary care and prescription diets to prolong their companions' lives. The American Pet Products Association's '2024-2025 National Pet Owners Survey' reported total U.S. pet industry expenditures of $147 billion in 2023, indicating a strong capacity for healthcare spending. This financial readiness supports the adoption of therapeutic solutions, with the Association for Pet Obesity Prevention reporting in May 2024 that 16% of dog owners and 25% of cat owners utilized therapeutic weight-loss diets.

Market Challenge

A fundamental restraint on the Global Pet Obesity Management Market is the substantial disparity between actual pet body condition and owner perception. This cognitive disconnect severely limits market penetration, as owners who fail to recognize weight issues are unlikely to seek pharmaceutical interventions or purchase therapeutic nutritional formulations. The inability to identify excess weight precludes necessary veterinary consultations for prescribing management solutions, thereby rendering a significant portion of the clinically addressable population inaccessible to manufacturers and suppressing demand despite the high prevalence of obesity.

Industry data underscores the magnitude of this obstacle, with UK Pet Food reporting in 2024 that while veterinary professionals classified 50% of dogs and 43% of cats as overweight or obese, 77% of owners believed their pets were at a healthy weight. This stark contrast illustrates that a vast majority of potential consumers remain unaware of their pet's medical needs, preventing the market from capitalizing on the actual volume of obesity cases. Consequently, revenue growth is impeded not by the absence of effective treatments, but by the end-user's inability to acknowledge the underlying problem.

Market Trends

The emergence of GLP-1 receptor agonist medications marks a transformative shift in the market, transitioning from traditional caloric restriction to pharmaceutical interventions comparable to human obesity treatments. These long-acting injectables leverage biological mechanisms to regulate appetite and enhance metabolic function, offering an alternative to strict dietary compliance. According to an April 2025 article by PetfoodIndustry, approximately one in three pet owners expressed willingness to use prescription weight-loss drugs for their pets if proven safe and effective, signaling a high potential for rapid adoption as owners increasingly medicalize weight management to mitigate health risks.

Simultaneously, the integration of wearable pet activity trackers is reshaping weight management strategies by offering objective data on energy expenditure to counter sedentary habits. Unlike subjective observations, these devices employ accelerometer technology to monitor activity levels and caloric burn, allowing veterinarians to design precise exercise regimens based on real-time metrics. This technology fosters a feedback loop that enhances owner engagement and adherence to rehabilitation protocols, a trend evidenced by Tractive's report in January 2025 of having over 1.3 million active subscribers utilizing their tracking solutions.

Key Market Players

  • Mars Incorporated
  • Hill's Pet Nutrition, Inc.
  • Nestle S.A
  • Farmina Pet Foods Holding B.V.
  • Drools Pet Food Pvt. Ltd.
  • NOW Health Group, Inc.
  • Virbac S.A.
  • VioVet Ltd
  • Rolf C. Hagen Inc.
  • Vivaldis Health & Foods Pvt. Ltd.
  • Neogen Corporation

Report Scope

In this report, the Global Pet Obesity Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pet Obesity Management Market, By Animal Type

  • Dogs
  • Cats
  • Others

Pet Obesity Management Market, By Product

  • Therapeutic Food
  • Supplements

Pet Obesity Management Market, By Distribution Channel

  • Pet Specialty Stores
  • E-Commerce
  • Others

Pet Obesity Management Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pet Obesity Management Market.

Available Customizations:

Global Pet Obesity Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pet Obesity Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Dogs, Cats, Others)
    • 5.2.2. By Product (Therapeutic Food, Supplements)
    • 5.2.3. By Distribution Channel (Pet Specialty Stores, E-Commerce, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Pet Obesity Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type
    • 6.2.2. By Product
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pet Obesity Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Pet Obesity Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Pet Obesity Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Distribution Channel

7. Europe Pet Obesity Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type
    • 7.2.2. By Product
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pet Obesity Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Pet Obesity Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Pet Obesity Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Pet Obesity Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Pet Obesity Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Pet Obesity Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type
    • 8.2.2. By Product
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pet Obesity Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Pet Obesity Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Pet Obesity Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Pet Obesity Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Pet Obesity Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Pet Obesity Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type
    • 9.2.2. By Product
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pet Obesity Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Pet Obesity Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Pet Obesity Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Distribution Channel

10. South America Pet Obesity Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type
    • 10.2.2. By Product
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pet Obesity Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Pet Obesity Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Pet Obesity Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pet Obesity Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Mars Incorporated
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hill's Pet Nutrition, Inc.
  • 15.3. Nestle S.A
  • 15.4. Farmina Pet Foods Holding B.V.
  • 15.5. Drools Pet Food Pvt. Ltd.
  • 15.6. NOW Health Group, Inc.
  • 15.7. Virbac S.A.
  • 15.8. VioVet Ltd
  • 15.9. Rolf C. Hagen Inc.
  • 15.10. Vivaldis Health & Foods Pvt. Ltd.
  • 15.11. Neogen Corporation

16. Strategic Recommendations

17. About Us & Disclaimer